Idalbi Tablet 20 mg (Azilsartan Medoxomil Potassium)
Potassium Azilsartan Medoxomil 21.34mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
MFDS item code 201702620 · Approved 2017.05.26
This product's status changed to Approval withdrawn on 2024.05.08. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension refers to a chronic state of elevated blood pressure. This condition can impact cardiovascular health, hence requires proper management and treatment. This medication helps control blood pressure in patients with essential hypertension to prevent complications. It is important to maintain healthy lifestyle habits along with regular dosing. This drug is used for the treatment of essential hypertension.
The recommended initial dose of this medicine is 40 milligrams once daily, with or without food. If blood pressure is not adequately controlled at this dose, the dose may be increased to a maximum of 80 milligrams daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum effect at about 4 weeks. If blood pressure is not controlled with this medicine alone, additional blood pressure-lowering effects may occur when it is used in combination with other antihypertensive agents [diuretics (e.g., chlorthalidone, hydrochlorothiazide) or calcium channel blockers]. No initial dose adjustment is necessary when administering this medicine to patients aged 65 years and older. For very elderly patients (aged 75 years and older) at risk of hypotension, an initial dose of 20 milligrams may be considered. No dose adjustment is necessary in patients with mild to moderate renal impairment. Use with caution in patients with severe renal impairment or end-stage renal disease (ESRD), as there is no experience with the use of this medicine in these patients. Azilsartan is not removed by hemodialysis. This medicine is not recommended in patients with severe hepatic impairment because it has not been studied in these patients. Experience with its use in patients with mild to moderate hepatic impairment is limited; close monitoring is recommended, and an initial dose of 20 milligrams may be considered. In patients with reduced salt levels or a risk of effective circulating blood volume depletion (e.g., those with vomiting or diarrhea or receiving high doses of diuretics), initiate treatment with this medicine under close medical supervision and consider an initial dose of 20 milligrams.
The safety and efficacy of this medicine in children and adolescents under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, thus it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this medication, pregnant, or have certain kidney disorders or diabetes should not use this medication. Careful use is required in patients with severely impaired heart or kidney function, kidney vascular issues, and patients at risk of sudden drops in blood pressure. Caution is necessary when this drug is used with certain diuretics or other antihypertensives as it may increase the risk of hypotension, decreased kidney function, and elevated potassium levels. Side effects such as dizziness, hypotension, nausea, rash, and muscle cramps may occur, especially when starting this medication or adjusting the dosage. Dizziness or drowsiness may occur while driving or operating machinery, so caution should be taken. During the course of this medication, regular blood tests to monitor kidney function and potassium levels are important. In case of overdose, symptoms such as hypotension and dizziness may present, and immediate notification to medical personnel is necessary. This medication should be stored in its original packaging, avoiding light and moisture, and kept out of reach of children. Women who are pregnant or breastfeeding are advised not to use this medication, and if necessary, consideration should be given to alternative therapies.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that blocks light and air, preferably at a temperature between 1°C and 30°C. Additionally, it should be kept away from humid areas to maintain its efficacy and safety.
White or almost white round tablets
PTP packaging: 14 tablets, 28 tablets, 30 tablets, 56 tablets, 90 tablets, 98 tablets/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Potassium Azilsartan Medoxomil 21.34mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Potassium Azilsartan Medoxomil 85.36mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Potassium Azilsartan Medoxomil 42.68mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Potassium Azilsartan Medoxomil 42.68mg
Tablet · Prescription medication
Celltrion Healthcare Co., Ltd.

Potassium Azilsartan Medoxomil 85.36mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Potassium Azilsartan Medoxomil 21.34mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.